Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.
Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.
复制标题
19q13.33的遗传多态性与[-2]proPSA(p2PSA)水平相关,并为前列腺癌的前列腺健康指数提供额外的预测价值。
DOI:
10.1002/pros.24192
复制
发表时间:
2021-09
期刊:
影响因子:
--
通讯作者:
Na R
中科院分区:
文献类型:
--
作者:
Huang D;Ruan X;Wu Y;Lin X;Huang J;Ye D;Gao Y;Ding Q;Xu D;Na R
Prostate health index (phi), a derivative of [−2]proPSA (p2PSA), has shown better accuracy than prostate‐specific antigen (PSA) in prostate cancer (PCa) detection. The present study was to investigate whether previously identified PSA‐associated single nucleotide polymorphisms (SNPs) influence p2PSA or phi levels and lead to potential clinical utility. We conducted an observational prospective study with 2268 consecutive patients who underwent prostate biopsy in three tertiary medical centers from August 2013 to March 2019. Genotyping data of the 46 candidate genes with a ± 100 kb window were tested for association with p2PSA and phi levels using linear regression. Multivariable logistic regression models were performed and internally validated using repeated tenfold cross‐validation. We further calculated personalized phi cutoff values based on the significant genotypes. Discriminative performance was assessed using decision curve analysis and net reclassification improvement (NRI) index. We detected 11 significant variants at 19q13.33 which were p2PSA‐associated independent of PCa. The most significant SNP, rs198978 in KLK2 (P combined = 5.73 × 10−9), was also associated with phi values (P combined = 3.20 × 10−6). Compared to the two commonly used phi cutoffs of 27.0 and 36.0, the personalized phi cutoffs had a significant NRI for PCa ranged from 5.23% to 9.70% among men carrying variant types (all p < .01). Rs198978, is independently associated with p2PSA values, and can improve the diagnostic ability of phi for PCa using personalized cutoff values.
登录
查看更多内容
影响因子:
5.3
作者:
Kote-Jarai Z;Amin Al Olama A;Leongamornlert D;Tymrakiewicz M;Saunders E;Guy M;Giles GG;Severi G;Southey M;Hopper JL;Sit KC;Harris JM;Batra J;Spurdle AB;Clements JA;Hamdy F;Neal D;Donovan J;Muir K;Pharoah PD;Chanock SJ;Brown N;Benlloch S;Castro E;Mahmud N;O'Brien L;Hall A;Sawyer E;Wilkinson R;Easton DF;Eeles RA
通讯作者:
Eeles RA
影响因子:
30.8
作者:
Marchini, Jonathan;Howie, Bryan;Donnelly, Peter
通讯作者:
Donnelly, Peter
影响因子:
23.4
作者:
Aly, Markus;Wiklund, Fredrik;Xu, Jianfeng;Isaacs, William B.;Eklund, Martin;D'Amato, Mauro;Adolfsson, Jan;Gronberg, Henrik
通讯作者:
Gronberg, Henrik
影响因子:
6.4
作者:
Johansson, Mattias;Holmstrom, Benny;Stattin, Par
通讯作者:
Stattin, Par
DOI:
10.1093/jnci/95.12.868
发表时间:
2003-06-18
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
Draisma, G;Boer, R;de Koning, HJ
通讯作者:
de Koning, HJ